首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

2126656

獸用抗菌劑和抗生素市場：依產品種類、動物種類、給藥方法及地區分類。

Animal Antimicrobials And Antibiotics Market, By type of product, By type of animals, By mode of delivery, By Geography

出版日期: 2026年08月26日 | 出版商:

Coherent Market Insights | 英文 257 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，獸用抗菌藥物和抗生素市場規模將達到 56 億美元，到 2033 年將達到 63 億美元。預計 2026 年至 2033 年的複合年成長率為 1.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	56億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	1.90	2033年市場規模預測：	63億美元

獸用抗菌藥物和抗生素市場在維護動物健康方面發揮著至關重要的作用，它們提供治療藥物，用於預防和控制牲畜、伴侶動物和養殖魚類的細菌及其他微生物感染疾病。獸醫和畜牧養殖戶使用這些藥物來控制感染疾病、保護動物健康並最大限度地減少疾病造成的損失。主要產品類型包括四環黴素、青黴素類、大環內酯類、Aminoglycosides和磺胺類藥物。畜牧業生產的成長、寵物數量的增加以及人們對獸醫保健意識的提高，持續推動對高效抗菌藥物和抗生素產品的需求。

推動獸用抗菌藥物和抗生素市場成長的因素包括動物感染疾病率的上升以及對動物性食品需求的不斷成長。製藥公司正在開發先進的配方、標靶治療和替代抗菌療法，以改善治療效果並應對抗生素抗藥性問題。監管機構也在實施更嚴格的指導方針，以促進獸醫領域合理使用抗生素。對動物保健投入的增加、水產養殖業的擴張以及獸醫服務可及性的提高，都為全球製造商創造了新的機會。

市場動態

隨著感染疾病對牲畜、伴侶動物和養殖動物的影響日益擴大，獸用抗菌藥物和抗生素市場也持續成長。農民和獸醫使用抗菌產品來保護動物健康、控制疾病爆發並最大限度地減少生產損失。全球肉類、乳製品和其他動物性產品消費量的成長促使生產者採取有效的動物健康管理措施。同時，寵物數量的增加和獸醫保健成本的上升也持續推動已開發市場和新興市場對抗生素和抗菌藥物的需求。

技術創新和藥物研發持續推動市場發展。製造商正在開發改良配方、長效療法、標靶治療和聯合製劑，以增強療效並簡化給藥方式。此外，為應對日益嚴重的抗生素抗藥性問題，各公司正加大對疫苗、益生菌和其他非抗生素替代療法的投入。獸醫診斷技術的進步使專家能夠更準確地識別感染疾病並選擇合適的治療方案。這些進展有助於合理使用抗生素，改善疾病管理，並最終提升動物健康水準。

然而，抗生素抗藥性、嚴格的監管以及日益增多的抗生素使用限制，都為參與企業帶來了挑戰。監管機構正在倡導負責任的處方實踐，並限制不必要的抗生素使用，這可能會影響產品需求。製造商還必須解決食用動物體內藥物殘留及其潛在環境影響的問題。儘管如此，獸醫基礎設施的不斷完善、動物疾病監測系統的改進、水產養殖產量的成長以及對預防性動物保健解決方案日益成長的需求，都為企業開發安全、有效且負責任的抗菌產品創造了機會。

本次調查的主要特點

該研究重點關注各個細分市場的潛在商機，並為參與動物抗菌藥物和抗生素市場的相關人員提供了一個有吸引力的投資提案矩陣。
本研究深入分析了市場促進因素、限制因素、機會、新興動物醫藥技術、抗生素抗藥性趨勢、產品創新、預防性動物保健發展、監管趨勢、區域展望以及主要市場參與企業採取的競爭策略。
本研究根據公司簡介、產品系列、近期發展、技術進步、財務表現和策略舉措，分析了獸用抗菌藥物和抗生素市場的主要參與者。
本報告提供的見解將使獸醫、畜牧養殖戶、動物保健公司、製藥商、投資者、經銷商和經營團隊能夠就產品開發、獸藥投資、合理使用抗生素、市場擴張、戰略合作和動物疾病管理舉措做出明智的決策。
《動物抗菌劑和抗生素市場》報告的目標受眾廣泛，包括投資者、製藥公司、獸醫協會、畜牧養殖戶、水產養殖經銷商、研究機構、監管機構、新市場參與企業和金融相關人員。
相關人員可以透過「動物抗菌劑和抗生素市場」報告中提出的分析框架、競爭基準、技術評估、產品評估、市場區隔、區域分析和市場機會矩陣做出明智的策略決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Merck & Co., Inc.
- Zoetis, Inc.
- Bayer AG
- Virbac
- Eli Lilly Company
- Boehringer Ingelheim GmbH
- Vetoquinol SA
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Sanofi
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI522

Animal Antimicrobials And Antibiotics Market is estimated to be valued at USD 5.6 Bn in 2026 and is expected to reach USD 6.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.90%	2033 Value Projection:	USD 6.3 Bn

The Animal Antimicrobials and Antibiotics Market plays an important role in maintaining animal health by providing treatments that prevent and control bacterial and other microbial infections in livestock, companion animals, and aquaculture species. Veterinarians and animal producers use these medicines to manage infections, protect animal health, and minimize disease-related losses. Key product categories include tetracyclines, penicillins, macrolides, aminoglycosides, and sulfonamides. Increasing livestock production, growing pet ownership, and greater awareness of veterinary healthcare continue to drive demand for effective antimicrobial and antibiotic products.

Several factors support the growth of the Animal Antimicrobials and Antibiotics Market, including the rising occurrence of infectious diseases in animals and increasing demand for animal-derived food products. Pharmaceutical companies are developing advanced formulations, targeted therapies, and alternative antimicrobial treatments to improve therapeutic outcomes while addressing antimicrobial resistance concerns. Regulatory agencies are also implementing stricter guidelines to promote responsible antibiotic use in veterinary medicine. Increasing investments in animal healthcare, expanding aquaculture activities, and improved access to veterinary services are creating new opportunities for manufacturers worldwide.

Market Dynamics

The Animal Antimicrobials and Antibiotics Market is expanding as infectious diseases increasingly affect livestock, companion animals, and aquaculture species. Farmers and veterinarians use antimicrobial products to protect animal health, control disease outbreaks, and minimize production losses. Growing global consumption of meat, dairy, and other animal-derived products encourages producers to adopt effective animal health management practices. At the same time, rising pet ownership and higher spending on veterinary care continue to increase demand for antibiotics and antimicrobial treatments across developed and emerging markets.

Technological innovation and pharmaceutical research continue to shape the market. Manufacturers are developing improved formulations, long-acting treatments, targeted therapies, and combination products to enhance treatment effectiveness and simplify administration. Companies are also investing in vaccines, probiotics, and other non-antibiotic alternatives to address growing concerns about antimicrobial resistance. Advances in veterinary diagnostic technologies enable professionals to identify infections more accurately and select appropriate treatments. These developments promote responsible antimicrobial use while improving disease management and supporting better animal health outcomes.

However, antimicrobial resistance, stringent regulations, and increasing restrictions on antibiotic use create challenges for market participants. Regulatory authorities are promoting responsible prescribing practices and limiting unnecessary antimicrobial administration, which can influence product demand. Manufacturers must also manage concerns related to drug residues in food-producing animals and potential environmental effects. Nevertheless, expanding veterinary healthcare infrastructure, improved animal disease surveillance, growing aquaculture production, and rising demand for preventive animal health solutions create opportunities for companies to develop safe, effective, and responsible antimicrobial products.

Key Features of the Study

It highlights potential revenue opportunities across various market segments and provides attractive investment proposition matrices for stakeholders involved in the Animal Antimicrobials and Antibiotics Market.
This study offers key insights into market drivers, restraints, opportunities, emerging veterinary pharmaceutical technologies, antimicrobial resistance trends, product innovations, preventive animal healthcare developments, regulatory trends, regional outlook, and competitive strategies adopted by leading market participants.
It profiles key players in the Animal Antimicrobials and Antibiotics Market based on company overview, product portfolio, recent developments, technological advancements, financial performance, and strategic initiatives.
Key companies covered as part of this study include Merck & Co., Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC and Sanofi.
Insights from this report enable veterinarians, livestock producers, animal healthcare companies, pharmaceutical manufacturers, investors, distributors, and management teams to make informed decisions regarding product development, veterinary healthcare investments, antimicrobial stewardship, market expansion, strategic collaborations, and animal disease management initiatives.
The Animal Antimicrobials and Antibiotics Market report serves a wide range of stakeholders, including investors, pharmaceutical companies, veterinary organizations, livestock producers, aquaculture businesses, veterinary clinics, distributors, research institutions, regulatory organizations, new market entrants, and financial analysts.
Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, technology assessment, product evaluation, market segmentation, regional analysis, and market opportunity matrices presented in the Animal Antimicrobials and Antibiotics Market report.

Market Segmentation

By Type of Product: (Revenue, USD Bn, 2021-2033)
Penicillin
Tetracycline
Sulfonamides
Quinolones
Macrolides
Cephalosporin
Aminoglycoside
Others
By Type of Animals: (Revenue, USD Bn, 2021-2033)
Companion animals
Food-producing animals
By mode of delivery: (Revenue, USD Bn, 2021-2033)
Oral powder or solutions
Injections
Premix
Others
By Region: (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Merck & Co., Inc.
Zoetis, Inc.
Bayer AG
Virbac
Eli Lilly Company
Boehringer Ingelheim GmbH
Vetoquinol S.A.
Ceva Sante Animale
Dechra Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type of Products
- Market Snapshot, By Type of Animals
- Market Snapshot, By Mode of Delivery
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Animal Antimicrobials And Antibiotics Market, By Type of Products, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Penicillin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Tetracycline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Sulfonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Quinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Aminoglycoside
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Animal Antimicrobials And Antibiotics Market, By Type of Animals, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Companion animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Food-producing animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Animal Antimicrobials And Antibiotics Market, By Mode of Delivery, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral powder or solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Premix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Animal Antimicrobials And Antibiotics Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Product, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Animals, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Delivery, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Zoetis, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Virbac
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Eli Lilly Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Vetoquinol S.A
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Ceva Sante Animale
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Dechra Pharmaceuticals PLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views